From: Tuberculosis treatment adherence in the era of COVID-19
Overall | Pre-COVID | COVID | p | |
---|---|---|---|---|
Age in years, median (IQR) | 43 (30–57) | 39 (29–54) | 53 (37–60) | 0.082 |
Sex, n (%) | 0.477 | |||
Male | 33 (63%) | 19 (68%) | 14 (58%) | |
Female | 19 (37%) | 9 (32%) | 10 (42%) | |
Born outside US, n (%) | 0.182 | |||
No | 23 (44%) | 10 (36%) | 13 (54%) | |
Yes | 29 (56%) | 18 (64%) | 11 (46%) | |
Ethnicity, n (%) | 0.025 | |||
Not hispanic | 31 (60%) | 12 (43%) | 19 (79%) | |
Hispanic | 10 (19%) | 7 (25%) | 3 (13%) | |
Unknown/not reported | 11 (21%) | 9 (32%) | 2 (8%) | |
Race, n (%) | 0.364 | |||
Asian | 9 (17%) | 4 (14%) | 5 (21%) | |
Black/African American | 31 (60%) | 15 (54%) | 16 (67%) | |
White | 6 (12%) | 4 (14%) | 2 (8%) | |
Unknown/not reported | 6 (12%) | 5 (18%) | 1 (4%) | |
Experiencing homelessness, n (%) | 0.573 | |||
No | 45 (87%) | 22 (79%) | 23 (96%) | |
Yes | 5 (10%) | 4 (14%) | 1 (4%) | |
Unknown/not reported | 2 (4%) | 2 (7%) | 0 (0%) | |
HIV-infected, n (%) | 0.275 | |||
No | 51 (98%) | 28 (100%) | 23 (96%) | |
Yes | 1 (2%) | 0 (0%) | 1 (4%) | |
Tuberculosis classification, n (%) | 0.809 | |||
Pulmonary | 30 (58%) | 15 (54%) | 15 (63%) | |
Extrapulmonary | 17 (33%) | 10 (36%) | 7 (29%) | |
Both | 5 (10%) | 3 (11%) | 2 (8%) | |
AFB smear, n (%) | 0.290 | |||
Smear-negative | 29 (56%) | 18 (64%) | 11 (46%) | |
Smear-positive | 22 (42%) | 9 (32%) | 13 (54%) | |
Unknown/not reported | 1 (2%) | 1 (4%) | 0 (0%) |